Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Julie Khlevner, MD, AGAF, explains the impact of the FDA approval of linaclotide for pediatric IBS-C
2
Safety, tolerability of tenapanor in pediatric IBS-C patients, with Thomas Wallach, MD
3
Odevixibat demonstrates sustained pruritus and bile acid improvements in FIC1 deficiency
4
Wesley Kufel, PharmD, discusses doxycycline for post-exposure prevention of Lyme disease in young children
5










